Text Size

Exercise Capability and Training Effects in Diabetic Patients With Neuropathy

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT01760707
First received: January 2, 2013
Last updated: January 3, 2013
Last verified: November 2012
History of Changes
  Purpose

The purpose of the study was to investigate the effects of training on the exercise capability, balance performance, and microcirculation. Furthermore, to search the possible underlying mechanisms.


Condition Intervention
Diabetes Mellitus
Peripheral Neuropathy
 Behavioral: exercise training
Behavioral: usual care

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Exercise Capability and Training Effects in Diabetic Patients With Neuropathy

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by National Taiwan University Hospital:

Primary Outcome Measures:
  • Exercise capacity [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    oxygen consumption


Secondary Outcome Measures:
  • maximal oxygen pulse [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    maximal oxygen content in blood of each heart beat


Enrollment: 22
Study Start Date: November 2002
Study Completion Date: May 2003
Primary Completion Date: April 2003 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Exercise Training
aerobic exercise training
 Behavioral: exercise training
Active Comparator: Control Behavioral: usual care

  Eligibility

Ages Eligible for Study:   20 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Type 2 diabetes with neuropathy.

Exclusion Criteria:

  • Central nerve system dysfunction, hemiparesis, motion tremor, other musculoskeletal disease that might effect the outcome measurements.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01760707

Locations
Taiwan
National Taiwan University Hospital
Taipei, Taiwan, 100
Sponsors and Collaborators
National Taiwan University Hospital
Investigators
Study Director: Ying-Tai Wu, PhD National Taiwan University Hospital
  More Information

No publications provided

Responsible Party: National Taiwan University Hospital
ClinicalTrials.gov Identifier: NCT01760707     History of Changes
Other Study ID Numbers: 9200200769, NSC92-2314-B-002-130
Study First Received: January 2, 2013
Last Updated: January 3, 2013
Health Authority: Taiwan: Department of Health

Keywords provided by National Taiwan University Hospital:
Diabetes mellitus
Peripheral neuropathy
Exercise
Balance performance

Additional relevant MeSH terms:
Diabetes Mellitus
Peripheral Nervous System Diseases
Demyelinating Diseases
Polyneuropathies
Nerve Compression Syndromes
Neurologic Manifestations
Neurotoxicity Syndromes
Glucose Metabolism Disorders
 Metabolic Diseases
Endocrine System Diseases
Neuromuscular Diseases
Nervous System Diseases
Signs and Symptoms
Poisoning
Substance-Related Disorders

ClinicalTrials.gov processed this record on May 19, 2013